Annual CFI
$33.35 M
+$124.31 M+136.67%
December 31, 2023
Summary
- As of February 7, 2025, LRMR annual cash flow from investing activities is $33.35 million, with the most recent change of +$124.31 million (+136.67%) on December 31, 2023.
- During the last 3 years, LRMR annual CFI has risen by +$16.26 million (+95.16%).
- LRMR annual CFI is now at all-time high.
Performance
LRMR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$27.27 M
+$90.76 M+142.95%
September 30, 2024
Summary
- As of February 7, 2025, LRMR quarterly cash flow from investing activities is $27.27 million, with the most recent change of +$90.76 million (+142.95%) on September 30, 2024.
- Over the past year, LRMR quarterly CFI has increased by +$90.76 million (+142.95%).
- LRMR quarterly CFI is now -70.44% below its all-time high of $92.25 million, reached on March 31, 2023.
Performance
LRMR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$107.21 M
+$73.70 M+40.74%
September 30, 2024
Summary
- As of February 7, 2025, LRMR TTM cash flow from investing activities is -$107.21 million, with the most recent change of +$73.70 million (+40.74%) on September 30, 2024.
- Over the past year, LRMR TTM CFI has increased by +$73.70 million (+40.74%).
- LRMR TTM CFI is now -363.79% below its all-time high of $40.64 million, reached on June 30, 2020.
Performance
LRMR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
LRMR Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +136.7% | +142.9% | +40.7% |
| 3 y3 years | +95.2% | +142.9% | +40.7% |
| 5 y5 years | +10000.0% | +142.9% | +40.7% |
LRMR Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +136.7% | -70.4% | +139.9% | -421.4% | +40.7% |
| 5 y | 5-year | at high | +136.7% | -70.4% | +139.9% | -363.8% | +40.7% |
| alltime | all time | at high | +136.7% | -70.4% | +139.9% | -363.8% | +40.7% |
Larimar Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $27.27 M(-143.0%) | -$107.21 M(-40.7%) |
| Jun 2024 | - | -$63.49 M(-7.1%) | -$180.91 M(+42.2%) |
| Mar 2024 | - | -$68.36 M(+2500.4%) | -$127.26 M(-481.6%) |
| Dec 2023 | $33.35 M(-136.7%) | -$2.63 M(-94.3%) | $33.35 M(-305.2%) |
| Sep 2023 | - | -$46.43 M(+371.9%) | -$16.25 M(-160.7%) |
| Jun 2023 | - | -$9.84 M(-110.7%) | $26.79 M(+1977.1%) |
| Mar 2023 | - | $92.25 M(-276.6%) | $1.29 M(-101.4%) |
| Dec 2022 | -$90.96 M | -$52.23 M(+1443.6%) | -$90.96 M(+182.2%) |
| Sep 2022 | - | -$3.38 M(-90.4%) | -$32.24 M(-9.6%) |
| Jun 2022 | - | -$35.34 M(<-9900.0%) | -$35.64 M(-288.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $0.00(-100.0%) | $18.92 M(-21.7%) |
| Dec 2021 | $24.17 M(+41.4%) | $6.49 M(-195.6%) | $24.17 M(-512.0%) |
| Sep 2021 | - | -$6.79 M(-135.3%) | -$5.87 M(-739.7%) |
| Jun 2021 | - | $19.22 M(+266.0%) | $917.00 K(-96.0%) |
| Mar 2021 | - | $5.25 M(-122.3%) | $23.12 M(+35.3%) |
| Dec 2020 | $17.09 M(<-9900.0%) | -$23.55 M(>+9900.0%) | $17.09 M(-57.9%) |
| Sep 2020 | - | -$8000.00(-100.0%) | $40.63 M(-0.0%) |
| Jun 2020 | - | $41.42 M(-5424.0%) | $40.64 M(-5324.0%) |
| Mar 2020 | - | -$778.00 K | -$778.00 K |
| Dec 2019 | -$83.00 K | - | - |
FAQ
- What is Larimar Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Larimar Therapeutics?
- What is Larimar Therapeutics annual CFI year-on-year change?
- What is Larimar Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Larimar Therapeutics?
- What is Larimar Therapeutics quarterly CFI year-on-year change?
- What is Larimar Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Larimar Therapeutics?
- What is Larimar Therapeutics TTM CFI year-on-year change?
What is Larimar Therapeutics annual cash flow from investing activities?
The current annual CFI of LRMR is $33.35 M
What is the all time high annual CFI for Larimar Therapeutics?
Larimar Therapeutics all-time high annual cash flow from investing activities is $33.35 M
What is Larimar Therapeutics annual CFI year-on-year change?
Over the past year, LRMR annual cash flow from investing activities has changed by +$124.31 M (+136.67%)
What is Larimar Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of LRMR is $27.27 M
What is the all time high quarterly CFI for Larimar Therapeutics?
Larimar Therapeutics all-time high quarterly cash flow from investing activities is $92.25 M
What is Larimar Therapeutics quarterly CFI year-on-year change?
Over the past year, LRMR quarterly cash flow from investing activities has changed by +$90.76 M (+142.95%)
What is Larimar Therapeutics TTM cash flow from investing activities?
The current TTM CFI of LRMR is -$107.21 M
What is the all time high TTM CFI for Larimar Therapeutics?
Larimar Therapeutics all-time high TTM cash flow from investing activities is $40.64 M
What is Larimar Therapeutics TTM CFI year-on-year change?
Over the past year, LRMR TTM cash flow from investing activities has changed by +$73.70 M (+40.74%)